- Home
- GFR vs TKNO Comparison
GFR vs TKNO Comparison
Compare GFR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFR
- TKNO
- Stock Information
- Founded
- GFR 2018
- TKNO 1996
- Country
- GFR Canada
- TKNO United States
- Employees
- GFR N/A
- TKNO N/A
- Industry
- GFR
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- GFR
- TKNO Health Care
- Exchange
- GFR Nasdaq
- TKNO Nasdaq
- Market Cap
- GFR 318.9M
- TKNO 256.9M
- IPO Year
- GFR N/A
- TKNO 2021
- Fundamental
- Price
- GFR $5.25
- TKNO $4.35
- Analyst Decision
- GFR
- TKNO
- Analyst Count
- GFR 0
- TKNO 0
- Target Price
- GFR N/A
- TKNO N/A
- AVG Volume (30 Days)
- GFR 42.0K
- TKNO 224.0K
- Earning Date
- GFR 08-06-2025
- TKNO 08-07-2025
- Dividend Yield
- GFR N/A
- TKNO N/A
- EPS Growth
- GFR N/A
- TKNO N/A
- EPS
- GFR 2.05
- TKNO N/A
- Revenue
- GFR $516,308,125.00
- TKNO $38,923,000.00
- Revenue This Year
- GFR N/A
- TKNO $9.52
- Revenue Next Year
- GFR $27.03
- TKNO $15.20
- P/E Ratio
- GFR $2.52
- TKNO N/A
- Revenue Growth
- GFR N/A
- TKNO 11.40
- 52 Week Low
- GFR $3.81
- TKNO $4.00
- 52 Week High
- GFR $8.16
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- GFR 67.48
- TKNO 43.35
- Support Level
- GFR $4.14
- TKNO $4.22
- Resistance Level
- GFR $5.01
- TKNO $4.94
- Average True Range (ATR)
- GFR 0.25
- TKNO 0.29
- MACD
- GFR 0.07
- TKNO -0.00
- Stochastic Oscillator
- GFR 97.96
- TKNO 16.75
About GFR Greenfire Resources Ltd.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.